✦ LIBER ✦

Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer

✍ Scribed by Deng, Li-Li; Deng, Hong-Bin; Lu, Chang-Lian; Guo, Yang; Wang, Di; Yan, Chun-Hua; Lv, Xing; Shao, Yu-Xia

Book ID: 126468830
Publisher: Springer-Verlag
Year: 2014
Tongue: English
Weight: 249 KB
Volume: 140
Category: Article
ISSN: 1432-1335
DOI: 10.1007/s00432-014-1751-y

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Impact of TP53 and KRAS mutations on cis

Impact of TP53 and KRAS mutations on cisplatin-based adjuvant chemotherapy in non-small-cell lung cancer

✍ X. Ma; E. Brambilla; J.C. Soria; A. Dunant; A.L. Vataire; P. Hainaut; the IALT-B 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 85 KB

Patterns of EGFR, HER2, TP53, and KRAS M

Patterns of EGFR, HER2, TP53, and KRAS Mutations of p14arf Expression in Non-Small Cell Lung Cancers in Relation to Smoking History

✍ Mounawar, M.; Mukeria, A.; Le Calvez, F.; Hung, R. J.; Renard, H.; Cortot, A.; B 📂 Article 📅 2007 🏛 American Association for Cancer Research 🌐 English ⚖ 339 KB

Radiation Therapy for Brain Metastases i

Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer: Significance of Mutations in EGFR, ALK, or KRAS on Radiation Therapy Response and Survival

✍ Mak, K.S.; Gainor, J.F.; Niemierko, A.; Oh, K.S.; Willers, H.; Choi, N.C.; Loeff 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Influence of DNA repair gene polymorphis

Influence of DNA repair gene polymorphisms on prognosis in inoperable non-small cell lung cancer patients treated with radiotherapy and platinum-based chemotherapy

✍ Dorota Butkiewicz; Anna Drosik; Rafał Suwiński; Małgorzata Krześniak; Marek Rusi 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 942 KB

Randomized study of vinorelbine (VRB) or

Randomized study of vinorelbine (VRB) or vindesine (VDS) with cisplatin (P) and mitomycin (M) as induction chemotherapy in stage IIIB or IV non-small cell lung cancer (NSCLC) — Final results

✍ Kawaguchi, T; Kawahara, M; Furuse, K; Nishiwaki, Y; Horai, T; Saijo, N; Hasegawa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 107 KB

33 Use of 2nd line chemotherapy in patie

33 Use of 2nd line chemotherapy in patients who had received standard platinum based chemotherapy for stage IIIb/IV non-small-cell lung cancer between January 2007 and March 2010

✍ Irvine, L.; Maclaren, V. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 43 KB